# Selective expansion of gut antibiotic resistome and underlying pathways involved in type 1 diabetes

## TL;DR

This study finds that gut antibiotic resistance genes expand in type 1 diabetic rats and humans, linked to gut microbes and hyperglycemia.

## Contribution

The study identifies specific antibiotic resistance gene expansions and microbial associations in type 1 diabetes.

## Key findings

- Gut antibiotic resistome expands in type 1 diabetic rats and patients, including resistance to glycopeptides and beta-lactams.
- Resistome expansion correlates with hyperglycemia and specific gut microbes like Lactobacillus johnsonii.
- Peptidoglycan biosynthesis and antimicrobial peptide resistance are activated in diabetic rats.

## Abstract

Selective expansion of gut antibiotic resistance genes (including glycopeptides, tetracyclines, macrolide‐lincosamide‐streptogramins, and beta‐lactams) was observed in type 1 diabetic rats. Interestingly, a similar expansion of gut antibiotic resistome occurred in diabetic patients. Selective expansion of gut antibiotic resistome was correlated with hyperglycemia and gut microbial community (particularly order Lactobacillales, such as species Lactobacillus johnsonii, Limosilactobacillus urinaemulieris, and Streptococcus hyointestinalis). Furthermore, activation of peptidoglycan biosynthesis and beta‐lactam resistance, disturbances in vancomycin resistance, and activation of antimicrobial peptide resistance, lantibiotic biosynthesis and immunity, and transport of antibiotics, peptides, and amino acids were involved in selective expansion of gut antibiotic resistome in type 1 diabetic rats.